Targeting highly resisted anticancer drugs through topological descriptors using VIKOR multi-criteria decision analysis.

The disease cancer is expanding on high spans in virtually all over the world, and undoubtedly, the research through all the aspects of sciences for each of its perspective is a great cause in reducing its severeness and symptoms. Chemotherapy is itself a cure to cancer as it helps in controlling the formation of cancerous cells but leaving multiple side effects on a human body. In this research work, we targeted 21 anticancer drugs that are in taken by the patients in combinations during chemotherapies. We introduce another branch of mathematics named as OR (Operations Research) linking to the chemical graph theory. Chemical graph theory allows us to generate highly resistant research on any structure via quantitative structure property relationship (QSPR) modeling to explore and develop new compounds for drugs. In this research study, we visualized what else the QSPR could provide when it comes to ranking drugs. We visualized the results obtained for boiling points and enthalpy of vaporizations through QSPR as the values of correlation coefficients and the errors generated under unique QSPR modeling. The implementation of VIKOR provides the best ranking for each of anticancer drugs when keeping in concern the specified properties, and the conclusions from this research work show another path to biologist scientists to create best combinations keeping in concern the study generated from QSPR. Supplementary Information: The online version contains supplementary material available at 10.1140/epjp/s13360-022-03469-x.

Pakistan Oral Cancer Collaborative: analyzing barriers and obstacles to oral cancer diagnosis, treatment, and prevention in Pakistan.

Oral cancer is a global health problem with increasing case numbers worldwide and no significant improvement in prognosis over the last few decades. It is one of the most common cancers and a leading cause of death in Pakistan, although the number reported is significantly underreported owing to the lack of a national cancer repository, and the true magnitude of this challenge is not known. Bilateral discussions and workshops funded by the Global Challenges Research Fund brought together a number of like-minded researchers and clinicians from the United Kingdom and Pakistan to analyze the status quo and plan the future course. This article reviews some of these discussions as well as barriers to oral cancer diagnosis in Pakistan and makes recommendations to investigate the magnitude and develop measures that may help tackle this devastating disease.